Company: CORT
Filing Date: 2025-11-04
Form Type: 10-Q
Source: 0001628280-25-048841
Chunk: 94

Company: CORCEPT THERAPEUTICS INC
Filing Date: 2025-11-04
Form: 10-Q
Item: Part I, Item 8
Chunk 94
---
 interests or the interests of other stockholders and may prevent or delay a change in control. This significant concentration of share ownership may adversely affect the trading price of our common stock because many investors perceive disadvantages to owning stock in companies with controlling stockholders.

ITEM 2.  UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

There were no unregistered sales of equity securities during the period covered by this report.

Issuer Purchases of Equity Securities

The following table contains information relating to the repurchases of our common stock in the three months ended September 30, 2025 as part of our publicly announced stock repurchase program (in thousands, except average price per share):

Fiscal PeriodTotal Number of Shares RepurchasedAverage Price Paid Per ShareDollar Amount of Shares That May Yet be Purchased Under the Program(1)July 1, 2025 to July 31, 2025— $— $53,887 August 1, 2025 to August 31, 2025528 69.76 17,031 September 1, 2025 to September 30, 202582 68.47 11,424 Total610 $69.59 $11,424 

(1) On January 8, 2024, our Board of Directors authorized the repurchase of up to $200 million of our common stock pursuant to our Stock Repurchase Program. The program may be modified, suspended or discontinued at any time without notice.

The following table contains information relating to the purchase of shares of our common stock in the three months ended September 30, 2025 as part of the cashless net exercises of stock options and vesting of restricted stock (in thousands, except average price per share):

Fiscal PeriodTotal Number of Shares Purchased(1)Average Price Per ShareTotal Purchase Price of Shares(2)July 1, 2025 to July 31, 202543 $73.08 $3,142 August 1, 2025 to August 31, 2025120 70.95 8,481 September 1, 2025 to September 30, 202531 72.32 2,272 Total194 $71.64 $13,895 

(1) In July 2025, we issued 63,175 shares of common stock as part of a net-share settlement of a